Mariner Wealth Advisors (Cincinnati)’s Meridian Bioscience Inc VIVO Stock Holding History

Mariner Wealth Advisors (Cincinnati)’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$469K	Buy	31,500 +75	+0.2%	+$1.16K	0.03%	200
2018 Q2	$500K	Buy	31,425 +85	+0.3%	+$1.27K	0.03%	195
2018 Q1	$445K	Buy	31,340 +775	+3%	+$11.5K	0.03%	204
2017 Q4	$428K	Buy	30,565 +5,580	+22%	+$81.7K	0.03%	197
2017 Q3	$357K	Buy	24,985 +1,805	+8%	+$25.8K	0.02%	202
2017 Q2	$365K	Buy	23,180 +2,215	+11%	+$31.9K	0.03%	197
2017 Q1	$289K	Buy	20,965 +599	+3%	+$8.38K	0.02%	219
2016 Q4	$360K	Sell	20,366 -484	-2%	-$8.5K	0.03%	190
2016 Q3	$402K	Buy	20,850 +575	+3%	+$11.3K	0.03%	179
2016 Q2	$395K	Buy	20,275 +2,600	+15%	+$51K	0.04%	179
2016 Q1	$364K	Sell	17,675 -1,875	-10%	-$36.9K	0.04%	180
2015 Q4	$401K	Buy	+19,550	New	+$375K	0.04%	167
2015 Q1	$284K	Buy	14,875 +3,825	+35%	+$70.7K	0.04%	147
2014 Q4	$182K	Buy	+11,050	New	+$190K	0.03%	175

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mariner Wealth Advisors (Cincinnati)'s VIVO Position: Q3 2018 in Review

Mariner Wealth Advisors (Cincinnati) increased its Meridian Bioscience Inc (VIVO) stake by 0.24% in Q3 2018, buying an estimated $1.16K and bringing the position to 31,500 shares worth $469K. The position accounts for 0.03% of the portfolio, ranked #200.

Mariner Wealth Advisors (Cincinnati) first reported a position in VIVO in Q4 2014 and has held it in 14 quarters since. The position peaked at $500K in Q2 2018. 177 funds tracked by Wall St. Rank hold VIVO as of Q3 2018.

Mariner Wealth Advisors (Cincinnati) held 31,500 shares of Meridian Bioscience Inc worth $469K as of Q3 2018.
Mariner Wealth Advisors (Cincinnati) bought 75 Meridian Bioscience Inc shares in Q3 2018, an estimated $1.16K.
Meridian Bioscience Inc made up 0.03% of Mariner Wealth Advisors (Cincinnati)'s portfolio in Q3 2018, its #200 holding.
Mariner Wealth Advisors (Cincinnati) first reported a position in Meridian Bioscience Inc in Q4 2014 and has held it in 14 quarters since.
Mariner Wealth Advisors (Cincinnati)'s Meridian Bioscience Inc position peaked at $500K in Q2 2018.
177 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2018.

Based on Mariner Wealth Advisors (Cincinnati)'s 13F filing for Q3 2018, filed 13 Nov 2018.